AsOf

Recorded or changed on this day 2026-11-08

451–500 of 46,473 claims, by entity. Everything on 2026-11-08 →

superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total equity · 22,388,135,000 United States dollar
Abbott Laboratories total equity: 22,388,135,000 United States dollar, claim clm_D23ECD8FDCAC · ended · superseded by clm_5DCA28624EBB · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly revenue · 10,928,000,000 United States dollar
Abbott Laboratories quarterly revenue: 10,928,000,000 United States dollar, claim clm_D28ACE81B29C · ended · superseded by clm_8A05921A46AB · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly net income · 538,000,000 United States dollar
Abbott Laboratories quarterly net income: 538,000,000 United States dollar, claim clm_D2D95C54C305 · ended · superseded by clm_1C02430C4950 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total equity · 21,526,000,000 United States dollar
Abbott Laboratories total equity: 21,526,000,000 United States dollar, claim clm_D31BB3649B18 · ended · superseded by clm_B7BFE3FD70B5 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · operating income · 2,867,000,000 United States dollar
Abbott Laboratories operating income: 2,867,000,000 United States dollar, claim clm_D45686CBE9CE · ended · superseded by clm_476A660B6C4B · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · net income · 7,071,000,000 United States dollar
Abbott Laboratories net income: 7,071,000,000 United States dollar, claim clm_D4753923237F · ended · superseded by clm_11981DF05BC7 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly operating income · 2,052,000,000 United States dollar
Abbott Laboratories quarterly operating income: 2,052,000,000 United States dollar, claim clm_D4D65248DFB6 · ended · superseded by clm_94C2592AE159 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total assets · 61,859,790,000 United States dollar
Abbott Laboratories total assets: 61,859,790,000 United States dollar, claim clm_D512D0F32419 · ended · superseded by clm_0F6ED49CB4F4 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total equity · 50,954,000,000 United States dollar
Abbott Laboratories total equity: 50,954,000,000 United States dollar, claim clm_D5EE83B1870A · ended · superseded by clm_233C6F73AC72 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · cash and equivalents · 4,091,000,000 United States dollar
Abbott Laboratories cash and equivalents: 4,091,000,000 United States dollar, claim clm_D5F76318A6D2 · ended · superseded by clm_6379D6E6764E · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · cash and equivalents · 3,137,000,000 United States dollar
Abbott Laboratories cash and equivalents: 3,137,000,000 United States dollar, claim clm_D60E926E5D8D · ended · superseded by clm_D5F76318A6D2 · 1 source (1 primary) · conf 0.95
valid: Two independent sources agree, or a primary source states it: the record asserts this claim.
Abbott Laboratories · cash and equivalents · 4,052,000,000 United States dollar
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly operating income · 1,301,149,000 United States dollar
Abbott Laboratories quarterly operating income: 1,301,149,000 United States dollar, claim clm_D67FB10D44D3 · ended · superseded by clm_19A69695BB00 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly net income · 615,000,000 United States dollar
Abbott Laboratories quarterly net income: 615,000,000 United States dollar, claim clm_D6BBD632FF41 · ended · superseded by clm_5F39464983EE · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total assets · 47,630,017,000 United States dollar
Abbott Laboratories total assets: 47,630,017,000 United States dollar, claim clm_D6BE0F2C8B81 · ended · superseded by clm_369D8CA1A11D · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly operating income · 1,669,000,000 United States dollar
Abbott Laboratories quarterly operating income: 1,669,000,000 United States dollar, claim clm_D714148AE67A · ended · superseded by clm_23C6088E7F70 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly research and development · 596,000,000 United States dollar
Abbott Laboratories quarterly research and development: 596,000,000 United States dollar, claim clm_D72480210DBD · ended · superseded by clm_5BDD75D9E730 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total equity · 31,399,000,000 United States dollar
Abbott Laboratories total equity: 31,399,000,000 United States dollar, claim clm_D7620A7ABE34 · ended · superseded by clm_9C4568F5F599 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total equity · 23,008,000,000 United States dollar
Abbott Laboratories total equity: 23,008,000,000 United States dollar, claim clm_D8D7C2D39205 · ended · superseded by clm_32290A5FC0E4 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · shares outstanding · 1,727,997,596 shares
Abbott Laboratories shares outstanding: 1,727,997,596 shares, claim clm_D91F2017CC04 · ended · superseded by clm_301BDC9105FC · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly operating income · 761,000,000 United States dollar
Abbott Laboratories quarterly operating income: 761,000,000 United States dollar, claim clm_D93B193C9846 · ended · superseded by clm_1340152CB9B1 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · shares outstanding · 1,739,836,465 shares
Abbott Laboratories shares outstanding: 1,739,836,465 shares, claim clm_D943BAA75A0F · ended · superseded by clm_F9BD3860CF3E · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total equity · 36,490,000,000 United States dollar
Abbott Laboratories total equity: 36,490,000,000 United States dollar, claim clm_D99C678FB2C8 · ended · superseded by clm_2C9B44DDBA52 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly revenue · 9,456,633,000 United States dollar
Abbott Laboratories quarterly revenue: 9,456,633,000 United States dollar, claim clm_D9ABEC05FB6F · ended · superseded by clm_4F0F9A9FCDF2 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total assets · 52,416,623,000 United States dollar
Abbott Laboratories total assets: 52,416,623,000 United States dollar, claim clm_D9EBDA9C23A0 · ended · superseded by clm_E59D8BD6F57C · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · revenue · 43,075,000,000 United States dollar
Abbott Laboratories revenue: 43,075,000,000 United States dollar, claim clm_DA5BB69D989B · ended · superseded by clm_6FD3450A3DD5 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · operating income · 8,084,515,000 United States dollar
Abbott Laboratories operating income: 8,084,515,000 United States dollar, claim clm_DB14BAE02A47 · ended · superseded by clm_476B36EDFB32 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · shares outstanding · 1,558,864,658 shares
Abbott Laboratories shares outstanding: 1,558,864,658 shares, claim clm_DB844C28FB13 · ended · superseded by clm_31493028904E · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · cash and equivalents · 2,060,000,000 United States dollar
Abbott Laboratories cash and equivalents: 2,060,000,000 United States dollar, claim clm_DBA8DBEBFC34 · ended · superseded by clm_AA75EDDF3D74 · 1 source (1 primary) · conf 0.95
valid: Two independent sources agree, or a primary source states it: the record asserts this claim.
Abbott Laboratories · SEC CIK · 0000001800
Abbott Laboratories SEC CIK: 0000001800, claim clm_DC766CB8ACA6 · valid · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly net income · 419,000,000 United States dollar
Abbott Laboratories quarterly net income: 419,000,000 United States dollar, claim clm_DD829B82B38C · ended · superseded by clm_77D0019EBF2D · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · shares outstanding · 1,736,058,536 shares
Abbott Laboratories shares outstanding: 1,736,058,536 shares, claim clm_DDC41F7C4050 · ended · superseded by clm_BBA1010F4237 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly revenue · 7,656,000,000 United States dollar
Abbott Laboratories quarterly revenue: 7,656,000,000 United States dollar, claim clm_DE1BAF682D4F · ended · superseded by clm_C0322CACEF5F · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · cash and equivalents · 4,112,022,000 United States dollar
Abbott Laboratories cash and equivalents: 4,112,022,000 United States dollar, claim clm_DE2BC508C752 · ended · superseded by clm_CD7C420909AE · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · shares outstanding · 1,751,219,743 shares
Abbott Laboratories shares outstanding: 1,751,219,743 shares, claim clm_DFFA512578F3 · ended · superseded by clm_A47E0BC1EDCE · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · net income · 4,423,000,000 United States dollar
Abbott Laboratories net income: 4,423,000,000 United States dollar, claim clm_E00F0EE99100 · ended · superseded by clm_87CC51296794 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total assets · 60,276,893,000 United States dollar
Abbott Laboratories total assets: 60,276,893,000 United States dollar, claim clm_E061E4681AB9 · ended · superseded by clm_311FA36284F8 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · net income · 5,963,000,000 United States dollar
Abbott Laboratories net income: 5,963,000,000 United States dollar, claim clm_E0C8ECF41AD1 · ended · superseded by clm_C538B005C944 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · shares outstanding · 1,545,815,965 shares
Abbott Laboratories shares outstanding: 1,545,815,965 shares, claim clm_E1CB9197DEA5 · ended · superseded by clm_0410A6F2C43D · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · cash and equivalents · 4,345,910,000 United States dollar
Abbott Laboratories cash and equivalents: 4,345,910,000 United States dollar, claim clm_E1E87B6DD7DE · ended · superseded by clm_9250460C542F · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · shares outstanding · 1,572,356,859 shares
Abbott Laboratories shares outstanding: 1,572,356,859 shares, claim clm_E1EBF63517AF · ended · superseded by clm_1DFA7D7F2069 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · shares outstanding · 1,469,152,033 shares
Abbott Laboratories shares outstanding: 1,469,152,033 shares, claim clm_E22E26C7A5C9 · ended · superseded by clm_9FA1445E4402 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · cash and equivalents · 5,001,000,000 United States dollar
Abbott Laboratories cash and equivalents: 5,001,000,000 United States dollar, claim clm_E25A94C67D09 · ended · superseded by clm_1FC299F54EDD · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly operating income · 758,000,000 United States dollar
Abbott Laboratories quarterly operating income: 758,000,000 United States dollar, claim clm_E25EFE866047 · ended · superseded by clm_5F9689E3114D · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · cash and equivalents · 3,065,000,000 United States dollar
Abbott Laboratories cash and equivalents: 3,065,000,000 United States dollar, claim clm_E32F9485C0C9 · ended · superseded by clm_6AD344300D4A · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total equity · 31,602,000,000 United States dollar
Abbott Laboratories total equity: 31,602,000,000 United States dollar, claim clm_E37A9F632E3D · ended · superseded by clm_E93715A27F70 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly net income · 1,779,000,000 United States dollar
Abbott Laboratories quarterly net income: 1,779,000,000 United States dollar, claim clm_E37C754C8FCC · ended · superseded by clm_2BCC0DA601EA · 1 source (1 primary) · conf 0.95
valid: Two independent sources agree, or a primary source states it: the record asserts this claim.
Abbott Laboratories · ticker · ABT
Abbott Laboratories ticker: ABT, claim clm_E39037FF4684 · valid · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · research and development · 2,440,000,000 United States dollar
Abbott Laboratories research and development: 2,440,000,000 United States dollar, claim clm_E3A1981FFAA1 · ended · superseded by clm_CCB485006F63 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · net income · 4,728,000,000 United States dollar
Abbott Laboratories net income: 4,728,000,000 United States dollar, claim clm_E3BAB111231C · ended · superseded by clm_E0C8ECF41AD1 · 1 source (1 primary) · conf 0.95

What the statuses mean